tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for Janux Therapeutics Despite Challenges and Promising Market Potential
PremiumRatingsOptimistic Buy Rating for Janux Therapeutics Despite Challenges and Promising Market Potential
21d ago
Janux Therapeutics price target lowered to $150 from $200 at Cantor Fitzgerald
Premium
The Fly
Janux Therapeutics price target lowered to $150 from $200 at Cantor Fitzgerald
21d ago
Janux Therapeutics price target lowered to $38 from $46 at Stifel
Premium
The Fly
Janux Therapeutics price target lowered to $38 from $46 at Stifel
21d ago
Janux Therapeutics price target lowered to $45 from $70 at H.C. Wainwright
PremiumThe FlyJanux Therapeutics price target lowered to $45 from $70 at H.C. Wainwright
21d ago
Optimistic Long-term Potential for Janux Therapeutics Despite Current Challenges
Premium
Ratings
Optimistic Long-term Potential for Janux Therapeutics Despite Current Challenges
21d ago
Janux Therapeutics price target lowered to $32 from $80 at Clear Street
Premium
The Fly
Janux Therapeutics price target lowered to $32 from $80 at Clear Street
21d ago
Janux Therapeutics reports ‘positive’ updated interim data for JANX007
PremiumThe FlyJanux Therapeutics reports ‘positive’ updated interim data for JANX007
22d ago
Promising Potential of Janux Therapeutics: Buy Rating on Strong Clinical and Growth Prospects
Premium
Ratings
Promising Potential of Janux Therapeutics: Buy Rating on Strong Clinical and Growth Prospects
28d ago
Janux Therapeutics initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Janux Therapeutics initiated with a Peer Perform at Wolfe Research
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100